LMR Partners’s Transmedics TMDX Stock Holding History

LMR Partners’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-29,446	Closed	-$2.32M	–	1311
2023 Q4	$2.32M	Buy	+29,446	New	+$1.78M	0.03%	443

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

LMR Partners's TMDX Position: Q1 2024 in Review

LMR Partners sold out of Transmedics (TMDX) in Q1 2024, closing a stake of 29,446 shares — an estimated $2.32M sold.

LMR Partners first reported a position in TMDX in Q4 2023 and held it in 1 quarter. The position peaked at $2.32M in Q4 2023. 263 funds tracked by Wall St. Rank hold TMDX as of Q1 2024.

LMR Partners reported no remaining Transmedics position as of Q1 2024 after selling out during the quarter.
LMR Partners sold 29,446 Transmedics shares in Q1 2024, an estimated $2.32M.
LMR Partners first reported a position in Transmedics in Q4 2023 and held it in 1 quarter.
LMR Partners's Transmedics position peaked at $2.32M in Q4 2023.
263 funds tracked by Wall St. Rank held Transmedics as of Q1 2024.

Based on LMR Partners's 13F filing for Q1 2024, filed 15 May 2024.